• Outer Membrane Vesicles Enable Rapid mRNA Display for Tumor

  2026-07-13

  The referenced study pioneers a bacteria-derived outer membrane vesicle (OMV) platform for swift and effective surface display and delivery of personalized mRNA antigens, offering a distinct alternative to lipid nanoparticles. This advance streamlines mRNA vaccine preparation and enhances antitumor immune responses, holding significant implications for customizable cancer immunotherapy workflows.

• Proteoform-Specific Drug Targeting in Native Cell Signaling

  2026-07-13

  Lutomski et al. introduce a native top-down mass spectrometry workflow to resolve proteoform-specific interactions in intact cell membranes. This innovation clarifies how post-translational modifications and alternative splicing affect drug binding, with direct implications for the safety and selectivity of cGMP-specific phosphodiesterase type 5 inhibitors such as sildenafil.

• Cyclo (-RGDfC): Optimizing Integrin-Targeted Tumor Assays

  2026-07-12

  Cyclo (-RGDfC) empowers researchers to dissect integrin αvβ3-driven tumor biology with exceptional specificity and stability. This cyclic peptide uniquely supports robust, reproducible assays for cancer research, angiogenesis modeling, and targeted delivery workflows.

• EdU Imaging Kits (Cy3) for High-Precision S-Phase Detection

  2026-07-10

  EdU Imaging Kits (Cy3) deliver rapid, antibody-free detection of proliferating cells, outperforming legacy BrdU assays in both sensitivity and workflow simplicity. Unlock robust, reproducible S-phase analysis with click chemistry, empowering advanced cancer and genotoxicity research.

• BIRB 796 (Doramapimod): Dual-Action p38α MAPK Inhibition Dec

  2026-07-09

  Explore the latest mechanistic insights into BIRB 796 (Doramapimod), a highly selective p38α MAPK inhibitor. This article uniquely dissects its dual-action mechanism and practical implications for inflammation and apoptosis research.

• Translating HDM2 Antagonism: Serdemetan’s Role in Precision

  2026-07-09

  This thought-leadership article explores the mechanistic foundations and translational strategies for leveraging JNJ-26854165 (Serdemetan) as a selective HDM2 inhibitor in cancer research. Integrating emerging in vitro evaluation frameworks and competitive insights, it guides researchers toward impactful use of Serdemetan in p53-driven anti-proliferative, apoptosis, and radiosensitization workflows, while highlighting future opportunities and limitations.

• QPRT Drives Breast Cancer Invasion via PLC-Dependent Signali

  2026-07-08

  Liu et al. (2021) uncover a mechanistic link between quinolinate phosphoribosyltransferase (QPRT) upregulation and enhanced invasiveness in breast cancer cells, mediated through the phosphorylation of myosin light chain via the phospholipase C (PLC) pathway. Their work highlights potential therapeutic targets within NAD+ metabolism and PLC signaling for inhibiting breast cancer metastasis.

• Actinomycin D in Translational Research: Mechanisms and Stra

  2026-07-08

  Explore how Actinomycin D (ActD) empowers translational researchers to dissect transcriptional regulation, apoptosis, and mRNA stability, bridging mechanistic insight with strategic, evidence-backed experimental design. This thought-leadership article leverages emerging studies in neurogenesis and cancer research, contrasts competitive assay approaches, and articulates a forward-looking vision for ActD-driven innovation.

• UTP Solution: Precision Reagent for RNA Synthesis and Metabo

  2026-07-07

  UTP Solution (100 mM) from APExBIO is a high-purity, DNase/RNase-free nucleotide triphosphate designed for sensitive RNA and metabolic workflows. Its validated stability and exceptional purity make it a cornerstone for reproducible in vitro transcription, RNA amplification, and carbohydrate metabolism studies.

• Hydrocortisone in Research: Optimizing Glucocorticoid Hormon

  2026-07-07

  Hydrocortisone’s precision as a glucocorticoid hormone unlocks robust modeling of anti-inflammatory pathways, barrier protection, and neuroprotection in cell and animal systems. This article delivers executable protocols, evidence-driven troubleshooting, and strategic insights that help researchers maximize reproducibility and impact in inflammation and stress response studies.

• Cell Senescence β-Galactosidase Staining Kit: Workflow & Ins

  2026-07-06

  The Cell Senescence β-Galactosidase Staining Kit (APExBIO K2185) offers unparalleled specificity in detecting SA-β-Gal activity, streamlining senescent cell identification for both drug screening and mechanistic aging research. Optimized chemistry and compatibility with standard labware minimize artifacts and maximize reproducibility, making it a trusted choice for targeted cellular senescence assays.

• Hippo Kinases MST1/2 Regulate Macrophage Death Pathways

  2026-07-06

  This article reviews how the Hippo kinases MST1 and MST2 integrate signals from both sterile inflammation and bacterial pathogens to regulate macrophage programmed cell death. The study reveals how MST1/2 cleavage coordinates apoptosis and pyroptosis, with significant implications for immunity and cancer biology.

• Phospho-Tau Ser356 as an Alzheimer’s Target: Insights from N

  2026-07-05

  Taylor et al. (2023) identify phosphorylation of tau at serine 356 (p-tau Ser356) as closely linked to Alzheimer’s pathology and demonstrate that NUAK kinase inhibition can selectively reduce p-tau Ser356 levels in both mouse and human brain tissues. These findings inform the design of translational neuroscience experiments and highlight the importance of cell-type and tissue context in therapeutic targeting.

• Cabozantinib (XL184): Optimizing RCC Signaling & Motility As

  2026-07-04

  Cabozantinib (XL184) enables time-resolved dissection of kinase-driven adaptation and resistance in renal cell carcinoma research. This article translates systems-level phosphoproteomics findings into actionable workflows, troubleshooting tips, and protocol enhancements for robust signaling and motility studies.

• Virus-Mimicking Nanoparticles Enable Extrahepatic mRNA Deliv

  2026-07-03

  This study presents a bottom-up engineered, self-assembling enveloped virus-mimicking particle (EVMP) system for targeted mRNA delivery beyond the liver. The innovation overcomes hepatic tropism and immunogenicity, enabling efficient gene therapy and functional protein expression in extrahepatic tissues.

16721 records 1/1115 page Next 12345 下5页 Last page